Eduardo Mancilla-Urrea

Statistics

Publications

Citations

418

H-Index

Active since

2010

Affiliations

Instituto Nacional de Cardiología(Current)

Bristol-Myers Squibb (United States)

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Eduardo Mancilla-Urrea is an author at Instituto Nacional de Cardiología specializing in immunosuppression in kidney transplantation, kidney transplantation, and transplant pharmacology.

Publications per year

2010–2017

Publications

Switching from Calcineurin Inhibitor-based Regimens to a Belatacept-based Regimen in Renal Transplant Recipients

Lionel Rostaing, P. Massari, Valter Duro Garcı́a et al. · Clinical Journal of the American Society of Nephrology · 2010 · 185 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Belatacept-Based Regimens Are Associated With Improved Cardiovascular and Metabolic Risk Factors Compared With Cyclosporine in Kidney Transplant Recipients (BENEFIT and BENEFIT-EXT Studies)

Yves Vanrenterghem, Barbara A. Bresnahan, Josep M. Campistol et al. · Transplantation · 2011 · 184 citations

Medicine, Pharmacology, Pharmacotherapy +16

Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients

Evelyn Katy Alvarez Salazar, Arimelek Cortés-Hernández, Germán Rodrigo Alemán-Muench et al. · Frontiers in Immunology · 2017 · 38 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment

Janette Furuzawa‐Carballeda, Ian C. Bostock, Guadalupe Lima et al. · Transplant Immunology · 2014 · 11 citations

Life Sciences, Immunology, Nephrology +13

1–4 of 4